NCT06860620View on ClinicalTrials.gov

Efficacy of Zinc Supplementation in Maintaining Sustained Remission in Children With Steroid-sensitive Nephrotic Syndrome

NACompletedINTERVENTIONAL

Enrollment

192

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Steroid-Sensitive Nephrotic Syndrome

Interventions

DRUG

Zinc supplementation plus standard treatment

children were given 5 mg of elemental zinc sulfate as a single daily dose for children less than 4 years of age and 10 mg for children more than 4 years of age for a total duration of 6 months, along with standard therapy.

Trial Locations (1)

66000

Nishtar Hospital, Multan

All Listed Sponsors

lead

Muhammad Aamir Latif

OTHER

NCT06860620 - Efficacy of Zinc Supplementation in Maintaining Sustained Remission in Children With Steroid-sensitive Nephrotic Syndrome | Biotech Hunter | Biotech Hunter